The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients
A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing lethal acute respiratory disease emerged in December 2019. The World Health Organization named this disease "COVID-19" and declared it a pandemic on March 11, 2020. Many studies have shown that mesenchymal stem cell...
Saved in:
Main Authors: | Faisal A. Alzahrani (Author), Islam M. Saadeldin (Author), Abrar Ahmad (Author), Dipak Kumar (Author), Esam I. Azhar (Author), Arif Jamal Siddiqui (Author), Bassem Kurdi (Author), Abdulrahim Sajini (Author), Abdulmajeed F. Alrefaei (Author), Sadaf Jahan (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Exosomes on Multiple Sclerosis
by: Hussein Baharlooi, et al.
Published: (2022) -
Identification of TBK1 inhibitors against breast cancer using a computational approach supported by machine learning
by: Arif Jamal Siddiqui, et al.
Published: (2024) -
The Immunomodulatory Properties of Mesenchymal Stem Cells
by: Junji Xu, et al.
Published: (2018) -
Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats
by: Faisal A. Alzahrani, et al.
Published: (2018) -
Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering
by: Haojiang Li, et al.
Published: (2019)